CD36 contributes to ovarian cancer metastasis [24], promotes epithelial-mesenchymal transition (EMT) in cervical cancer via TGFβ signaling [25], and accelerates gastric cancer metastasis through reprogramming lipid metabolism [26], highlighting its broad involvement in cancer progression. This evidence concerns the gene CD36 and cancer.